Linked Life Data

2277299

Source:http://linkedlifedata.com/resource/pubmed/id/2277299

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1991-3-7
pubmed:abstractText
We have traditionally pushed the limits of conservative candidate criteria for heart transplantation. We have been gratified by our results in the aged, the diabetic, and the mortally ill. Our inclusion of patients with malignant disease underscores our philosophy to include patients as candidates for transplantation for whom the procedure has reasonable expectation of success. We report here our early results of heart transplantation in 11 patients with malignant disease. Our survival rate in this group is 100%, and all patients are leading active lives with no evidence of recurrent or metastatic tumor. Immunosuppression protocols were adjusted on an individual basis determined by the chemotherapy dosage, duration, and relation to transplantation. Whenever possible a 1-year disease-free interval after completion of adequate cancer therapy is desired before transplantation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0887-2570
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
627-9; discussion 630
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:articleTitle
Heart transplantation in patients with malignant disease.
pubmed:affiliation
Hospital of the University Health Center of Pittsburgh, University of Pittsburgh School of Medicine, Department of Surgery, University of Pittsburgh, Pa.
pubmed:publicationType
Journal Article